Propanc Biopharma, Inc. filed its 10-K on Sep 28, 2022 for the period ending Jun 30, 2022. In this report its auditor, Salberg & Company, P.A., gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.00075 USD | -10.71% |
|
-20.00% | -93.33% |
1st Jan change | Capi. | |
---|---|---|
-93.33% | 137K | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- PPCB Stock
- News Propanc Biopharma, Inc.
- Propanc Biopharma, Inc. Auditor Raises 'Going Concern' Doubt